Rajiv Kumar Pruthi, MBBS

Rajiv Pruthi practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Rajiv Pruthi's NPI, 1154300549, was assigned on January 13, 2006. Rajiv Pruthi holds Minnesota license 34931.

Rajiv Pruthi's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Rajiv Pruthi's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Rajiv Pruthi is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Rajiv Pruthi to 1 more hospital, 1 clinical lab and 1 hospice, each named with a free account. Rajiv Pruthi's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Rajiv Pruthi practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Rajiv Pruthi's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Rajiv Pruthi is board certified in hematology by the American Board of Internal Medicine. Rajiv Pruthi is licensed in Minnesota.

CMS data shows 3,169 Medicare services from Rajiv Pruthi across 9 procedure codes in 2024, for 137 Medicare patients. Medicare paid $31,688 for them. Every service was in an office.

CMS counts 137 Medicare patients who saw Rajiv Pruthi in 2024. The largest group is 65 to 74, with 74 patients. 71% of them have high blood pressure, and 62% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rajiv Pruthi's median patient age at 59, with 53% women.

In 2024, Rajiv Pruthi wrote 36 Medicare Part D claims for 12 patients. 53% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $137 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

Rajiv Pruthi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Rajiv Pruthi as offering telehealth.

Dmand AI links 117 papers to Rajiv Pruthi, published from 2007 to 2025. 2020 was the busiest year, with 10. The most frequent topics are Hemophilia A, Hemorrhage and Anticoagulants. Rajiv Pruthi has published most often in Haemophilia. Rajiv Pruthi's most frequent co-authors are Aneel Arjun Ashrani, MBBS, Dong Chen, MD, MS, PhD and Meera Sridharan, MD.

Dmand AI links Rajiv Pruthi to 2 clinical trials. Conditions studied include Hemophilia B and Hemophilia A. American Thrombosis and Hemostasis Network sponsors the most, 2.

CMS Open Payments shows 59 general payments to Rajiv Pruthi from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 73% of the total. Instrumentation Laboratory Company paid the most, $20,101.